摘要:Clinically, NAFLD is the most common cause of asymptomatic increases in transaminases. NAFLD is also currently the most common liver disorder in developed countries, affecting 24% of the world's population. The prevalence of NAFLD in European societies is estimated in the range of 17-46% and shows an upward trend with the increasing incidence of obesity and type II diabetes. NAFLD occurs in about 7% of people without excess weight, however, they are usually people with impaired insulin sensitivity, leading a sedentary lifestyle, having an increased cardiovascular risk, with higher levels of hepatic lipids as a result of reduced fat accumulation and reduced mitochondrial activity in adipose tissue and increased de novo hepatic lipogenesis.
关键词:Clinically, NAFLD is the most common cause of asymptomatic increases in transaminases. NAFLD is also currently the most common liver disorder in developed countries, affecting 24% of the world's population. The prevalence of NAFLD in European societies is estimated in the range of 17-46% and shows an upward trend with the increasing incidence of obesity and type II diabetes. NAFLD occurs in about 7% of people without excess weight, however, they are usually people with impaired insulin sensitivity, leading a sedentary lifestyle, having an increased cardiovascular risk, with higher levels of hepatic lipids as a result of reduced fat accumulation and reduced mitochondrial activity in adipose tissue and increased de novo hepatic lipogenesis.